Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)

Market Cap	4.19B +65.4%
Revenue (ttm)	816.95M +7.0%
Net Income	95.72M +162.9%
EPS	0.17 +183.3%
Shares Out	577.21M
PE Ratio	42.71
Forward PE	n/a
Dividend	0.29 (4.03%)
Ex-Dividend Date	Sep 11, 2025

Volume	7,544,220
Average Volume	19,387,650
Open	7.29
Previous Close	7.25
Day's Range	7.21 - 7.32
52-Week Range	3.60 - 7.78
Beta	0.15
RSI	54.37
Earnings Date	Jan 20, 2026

About SHE:002107

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu tablets, Hedan tablets and capsules, Naoxueshu and Shenzhiling oral liquid, and Tongluo Huatan capsules; and drugs for musculoskeletal disorders, includ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 1,018
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002107

Financial Performance

In 2025, SHE:002107's revenue was 816.95 million, an increase of 6.96% compared to the previous year's 763.79 million. Earnings were 95.72 million, an increase of 162.93%.